ea0056p606 | Obesity | ECE2018
Voltas Arribas Beatriz
, Juan Carlos Sanchez
, Garcia Juan Carlos Ferrer
, Fullana Ana Artero
, Revert Pablo Sanz
, Alacid Cristian Marco
, Merseguer Mario Lopez
Introduction: Obesity is one of the most prevalent health problems in our society. The marketing of Liraglutide and the Naltrexone/Bupropion combination has been given the green light.Objectives: To analyze the differences in a series of 19 patients assigned to treatment with Liraglutide or Naltrexone/Bupropion.Material and methods: A descriptive analysis was carried out using Stata. 19 patients were included, 9 were treated with L...